Qure.ai powers Pulmonary Nodule Clinic at Thangam Cancer Centre
Delhi Delhi: Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India’s first AI-based incidental pulmonary nodule (IPN) detection clinic at Thangam Cancer Center in Namakkal, Tamil Nadu.
The initiative is part of Project BreatheEZ, a broader strategic collaboration between Qure.ai and Johnson & Johnson Medtech, India, designed to establish AI-powered IPN clinics across leading hospitals in India. These clinics will act as integrated screening hubs, optimising early detection, triaging, and follow-up care for lung cancer patients.
The Thangam Cancer Center IPN clinic is India’s first dedicated incidental pulmonary nodule (IPN) clinic, designed to systematically detect and track lung nodules using Qure.ai’s FDA-approved qXR solution as part of an integrated screening and care pathway. This structured, AI-powered incidental screening program, set up in a hospital setting, will be able to detect nodules as small as 6mm from a routine chest X-ray. This minimally invasive, cost-effective approach unlocks the possibility of diagnosing lung cancer at an early stage, giving patients a significantly better chance of survival and improved outcomes. Speaking about the launch, Dr. Saravana Rajamanickam MS, MCh, Director, Surgical Thoracic Oncology, Thangam Cancer Centre & Research Institute said, “Our vision has always been to bring the best of global healthcare technology to the people. With the launch of this AI-powered clinic, we are not only enhancing our ability to detect lung cancer early but also redefining cancer care for millions in India. Combining the precision of AI with advanced surgical techniques like robotics gives us a comprehensive pathway from early detection to advanced treatment under one roof.” Qure.ai’s qXR technology works by automatically flagging pulmonary nodules, an early indicator of lung cancer, on routine chest X-rays. The AI system also assists radiologists by providing malignancy risk scores, tracking nodule progression over time, and ensuring seamless care coordination between radiology, pulmonology, and oncology teams.
Prashant Warrier, CEO and Co-founder, Qure.ai, said, “At Qure.ai, we are committed to bridging critical healthcare gaps with AI. Partnering with Thangam Cancer Center to transform routine chest X-rays into an early warning tool is a powerful example of the potential of our AI solutions. We look forward to further scaling this model across India’s healthcare ecosystem.”
This hub-and-spoke model piloted at Thangam Cancer Center is expected to set a blueprint for similar AI-powered clinics across India, which will be supported by Johnson & Johnson MedTech, India.
Lung cancer remains one of the world’s deadliest cancers, primarily due to late diagnosis. India reports 112,000 new cases of lung cancer every year1, of which only 4% are detected in the early stages2. Most patients are diagnosed only when symptoms appear, by then limiting treatment options. This first-of-its-kind AI-powered clinic raises hopes for earlier detection, especially for non-smoking patients, who now make up a growing proportion of lung cancer cases in India and the rest of the world.
